Aziridine - Triazole Conjugates as a Novel Class of MMP-2 Inhibitors

Abstract

We report here the synthesis of a series of (aryltriazolyl)methylaziridines 1 and their evaluation as selective inhibitors of MMP-2.[2] They constitute a novel class of hydroxamic acid-free matrix metalloproteinase inhibitors